Search
Search Results
##search.searchResults.foundPlural##
-
ELEVATED P-SELECTIN IN SEVERE COVID-19: CONSIDERATIONS FOR THERAPEUTIC OPTIONS P-Selectine and COVID-19
1826PDF: 671HTML: 225 -
EFFICACY OF VENETOCLAX COMBINED WITH AZACITIDINE IN ELDERLY PATIENTS WITH RELAPSED ACUTE MYELOID LEUKEMIA
1376PDF: 728Suppl. Files: 310Html: 123 -
IS HEMOGLOBIN E GENE WIDELY SPREAD IN THE STATE OF MADHYA PRADESH IN CENTRAL INDIA? EVIDENCE FROM FIVE TYPICAL FAMILIES
1329PDF: 850HTML: 7921Untitled: 191 -
EFFICACY AND SAFETY OF SINOPHARM VACCINE FOR SARS-COV-2 AND BREAKTHROUGH INFECTIONS IN IRANIAN PATIENTS WITH HEMOGLOBINOPATHIES: A PRELIMINARY REPORT Sinopharm Vaccination in Iranian Patients with Hemoglobinopathies
1477PDF: 699HTML: 219 -
Fetal hemoglobin modifies the disease manifestation of severe Plasmodium falciparum malaria in adult patients with sickle cell anemia.
3208PDF: 884HTML: 748text and figure: 212 -
LATERAL SINUS THROMBOSIS IN OTOLOGY: A REVIEW
1534PDF: 917HTML: 4078Letter: 160 -
CONTINUOUS CULTURES OF PLASMODIUM FALCIPARUM ESTABLISHED IN TANZANIA FROM PATIENTS WITH ACUTE MALARIA In vitro Malaria cultures
1606PDF: 517HTML: 197 -
Ceftolozane-Tazobatam for febrile neutropenia treatment in hematologic malignancy patients colonized by multi-resistant Enterobacteriaceae: preliminary results from a prospective cohort study Ceftolozane-Tazobatam for febrile neutropenia
7789PDF: 701HTML: 201 -
PARASITIC INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
3648PDF: 1213HTML: 3869Untitled: 195Untitled: 244 -
HODGKIN LYMPHOMA IN OLDER PATIENTS: AN ORPHAN DISEASE?
2848PDF: 1330HTML: 3555Untitled: 181Untitled: 189Untitled: 167 -
SHORT HISTORY OF MALARIA AND ITS ERADICATION IN ITALY
4657PDF: 1850HTML: 11021Fig 1: 210Fig 2: 165Fig 3: 289Fig 4: 173Fig 5: 162Fig 6: 163Fig 7: 173Fig 8: 166 -
LYON-UNIVERSITY HOSPITAL EXPERIENCE WITH GEMTUZUMAB OZOGAMICIN THERAPY IN ACUTE MYELOID LEUKEMIA: A ‘REAL-LIFE’ STUDY Gemtuzumab ozogamicin in AML
1623PDF: 1139HTML: 234 -
SIMPLE PERIPHERAL BLOOD SMEAR FINDINGS OF COVID-19 PATIENTS PROVIDE INFORMATION ABOUT THE SEVERITY OF THE DISEASE AND THE DURATION OF HOSPITAL STAY. Peripheral blood smear and COVID-19 severity.
3180PDF: 1040HTML: 417 -
DEMOGRAPHICAL, VIRO-IMMUNOLOGICAL, CLINICAL AND THERAPEUTICAL CHARACTERISTICS OF HIV INFECTED PATIENTS IN A “EPIDEMIOLOGICALLY UNEXPLORED” REGION OF ITALY (CALABRIA REGION): THE CALABRHIV COHORT.
1571PDF: 775HTML: 1220Figure 1: 159Figure 2: 175Figure 3: 170 -
PROCALCITONIN AS A BIOMARKER OF BACTERIAL INFECTION IN SICKLE CELL VASO-OCCLUSIVE CRISIS.
2017PDF: 1020HTML: 15641COVER LETTER: 174 -
CHRONIC MYELOGENOUS LEUKEMIA (CML) IN THE ELDERLY
2846PDF: 1074HTML: 3021 -
ANTIFUNGAL PROPHYLAXIS IN IMMUNOCOMPROMISED PATIENTS
4229PDF: 1343HTML: 2029 -
The COVID-19 in Omani children with chronic Hemato-oncology diseases COVID-19 in Omani children with chronic Hemato-oncology diseases
785PDF: 670HTML: 296 -
CLINICAL ASPECTS OF UNCOMPLICATED AND SEVERE MALARIA
7766PDF: 4039HTML: 7310 -
DIAGNOSTIC ACCURACY OF CLINICAL TOOL ‘STOPS’ AND SERUM PROCALCITONIN FOR OPTIMIZING ANTIBIOTIC THERAPY IN NEONATAL SEPSIS STOPS and procalcitonin for optimizing antibiotics in neonatal sepsis
1531PDF: 556HTML: 364







